What did @alekosmos88 actually say?
The caption is doing more work than the transcript here. The spoken audio is garbled beyond any usable content, likely a transcription artifact. So we're working from what the creator wrote: after five weeks on Wegovy, they're down 8.1 kilograms. They acknowledge it's not as fast as they'd hoped, but the scale is moving down. That's the core claim.
To be clear about what we're fact-checking: this is a personal progress report, not a medical claim. The creator isn't promising Wegovy will work for everyone, isn't naming a dose, and isn't selling anything. They're sharing a number on a scale. That framing matters when we assess accuracy.
The caption's tone is honest in a useful way. "Może nie o tyle o ile tym chciała" translates roughly to "maybe not as much as I wanted." That kind of tempered expectation is actually more responsible than a lot of weight-loss content on this platform.
Does the science back this up?
An 8.1 kg loss in five weeks is on the higher end of what clinical data would predict, but it's not outside the range of real-world outcomes. It's worth unpacking why.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) followed 1,961 adults on semaglutide 2.4 mg weekly for 68 weeks. Mean weight loss was 14.9% of body weight. That averages out to roughly 1–2 kg per week early in treatment, when water weight and rapid metabolic changes drive faster initial losses.
Week one through six on GLP-1 receptor agonists often produces disproportionately fast results. Semaglutide suppresses appetite rapidly, and early weight loss includes significant fluid shifts. So 8.1 kg across five weeks, while faster than the trial average, is biologically plausible, especially for someone with a higher starting weight.
A 2023 real-world analysis (Rubino et al., Obesity, 2023) found that early responders to semaglutide, defined as losing more than 5% in the first 12 weeks, had significantly better long-term outcomes. So if this creator's numbers hold, that could be a meaningful clinical signal, not just a good week.
What did they get wrong (or right)?
Honestly? They got the framing right. There are no miracle claims here, no promises, no before-and-after manipulation. They got something wrong only by omission, which is common in short-form content rather than intentional deception.
What's missing: context about what else is driving the loss. Wegovy doesn't work in a vacuum. The STEP trials combined semaglutide with lifestyle intervention. If the creator changed their diet or activity level alongside starting the medication, that's contributing to the 8.1 kg. The number is real, but the attribution may be incomplete.
There's also no mention of side effects. Nausea, fatigue, and GI distress are common in early weeks of semaglutide treatment, particularly during dose escalation. That's not a criticism of this creator specifically, but 22,000 viewers deserve to know that a fast start sometimes comes with a rough adjustment period.
The hashtag "dieta" (diet) alongside "wegovy" at least implies food changes are in the picture. That's more honest than some creators who imply the medication alone is responsible for everything.
What should you actually know?
If you're considering Wegovy, or already on it, here's what this video doesn't tell you.
- Early weight loss on semaglutide is often faster than sustained loss. Weeks two through eight can look dramatic. The rate typically slows after the first couple of months as the body adjusts.
- Semaglutide is a prescription medication approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. It is not appropriate for everyone.
- The drug works best alongside dietary changes and increased physical activity. It is not a replacement for those behaviors, it makes them easier to sustain by reducing hunger signals.
- Stopping semaglutide abruptly is associated with weight regain. Rubino et al. (2022, Diabetes, Obesity and Metabolism) found participants regained about two-thirds of lost weight within a year of stopping. This is a long-term treatment for most people, not a short course.
- Compounded semaglutide is not the same as brand-name Wegovy. The FDA has flagged safety concerns with compounded versions. If you're on Wegovy, make sure your prescription is for the actual approved product from a licensed pharmacy.
This creator's experience is real and relatable. But one person's five-week result is not a promise. Clinical outcomes vary based on starting weight, dose, adherence, and metabolic factors that no TikTok video can account for.